Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer

Raymond C. Bergan, Doyle H. Waggle, Stephen K. Carter, Ivan D. Horak, William J. Slichenmyer, Michael L. Meyers

Urology · 2001 · 25 citations · 10 references

Concepts

References

10